Sudhir Dhirendra Pilgaonkar
Fortune : 109 M $ au 30/09/2026
Fortune : 109 M $ au 30/09/2026
Sudhir Dhirendra Pilgaonkar is the founder of Rubicon Research Ltd., founded in 1999, holding the title of Chief Commercial Officer.
Former jobs include Principal at Aventis Pharma SA and Principal at Hoechst Pharmaceuticals Ltd. Education history includes undergraduate studies at University Institute of Chemical Technology and undergraduate degree from the University of Mumbai, conferred in 1973.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/10/2025 | 6 435 000 ( 3,89% ) | 109 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RUBICON RESEARCH LIMITED | Fondateur | 06/05/1999 |
| Sociétés | Poste | Fin |
|---|---|---|
Hoechst Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University Institute of Chemical Technology
University Institute of Chemical Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoechst Pharmaceuticals Ltd. | |
Rubicon Research Ltd.
Rubicon Research Ltd. BiotechnologyHealth Technology Engages in research, development and production of pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national